Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Cash from Investing Activities (2022 - 2026)

HeartSciences (HSCS) has disclosed Cash from Investing Activities for 4 consecutive years, with -$15770.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 169.94% year-over-year to -$15770.0, compared with a TTM value of -$40097.0 through Oct 2025, up 67.94%, and an annual FY2025 reading of -$30188.0, up 75.9% over the prior year.
  • Cash from Investing Activities was -$15770.0 for Q4 2025 at HeartSciences, down from -$814.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$814.0 in Q3 2025 and bottomed at -$69228.0 in Q2 2024.
  • Average Cash from Investing Activities over 4 years is -$14642.4, with a median of -$7247.0 recorded in 2022.
  • The sharpest move saw Cash from Investing Activities crashed 1317.73% in 2024, then surged 88.72% in 2025.
  • Year by year, Cash from Investing Activities stood at -$7247.0 in 2022, then surged by 73.06% to -$1952.0 in 2023, then plummeted by 199.28% to -$5842.0 in 2024, then crashed by 169.94% to -$15770.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for HSCS at -$15770.0 in Q4 2025, -$814.0 in Q3 2025, and -$7812.0 in Q2 2025.